My grandson will be entering Pitt in the fall, to begin doctorate in microbiology.
It didn't mean much to me, until I saw the purchase of Hospira by Pfizer... and the sale price of $15 Billion.
Quote:
The drugmaker Pfizer Inc. said it would buy Hospira Inc. for about $15 billion to gain access to biosimilars, copies of biotech drugs made from living cells.
|
Pfizer To Buy Hospira For About $15 Billion - Business Insider
The underlying value seems to be Hospira's development of Biosimilars... a term I didn't understand. It looks to be the next advancement in lower cost, off copyright drugs.
More to learn about this here:
Biosimilar - Wikipedia, the free encyclopedia
Quote:
|
Even though the biosimilars market is rising, the price drop for biological drugs at risk of patent expiration will not be as great as for other generic drugs; in fact it has been estimated that the price for biosimilar products will be 65%-85% of their originators. Biosimilars are drawing market's attention since there is an upcoming patent cliff, which will put nearly 36% of the 140bn USD market for biologic drugs at risk (as of 2011), this considering only the top 10 selling products.
|
A little over my head, but as I see things like "three parent babies" nothing surprises me any more. In another thread someone mentioned genetic molecule changes as a means to eternal life.
Am afraid it won't be in time to help me.
Linear Mode
